Unknown

Dataset Information

0

The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL.

ABSTRACT:

SUBMITTER: Wichert MC 

PROVIDER: S-EPMC11635643 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL.

Wichert Maren Christiane MC   Fortner Colin C   Niedermayer Alexandra A   Bender Johanna J   Enzenmüller Stefanie S   Debatin Klaus-Michael KM   Meyer Lüder Hinrich LH   Seyfried Felix F  

Blood advances 20241201 23

Similar Datasets

Unknown Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies.
| S-EPMC8895453 | biostudies-literature
Unknown TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo.
| S-EPMC4742189 | biostudies-literature
Unknown Inhibition of Antiapoptotic BCL-XL, BCL-2, and MCL-1 Proteins by Small Molecule Mimetics.
| S-EPMC2935820 | biostudies-literature
Unknown The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA.
| S-EPMC9021261 | biostudies-literature
Unknown BH3-only proteins target BCL-xL/MCL-1, not BAX/BAK, to initiate apoptosis.
| S-EPMC6888900 | biostudies-literature
Unknown Discovery of <i>N</i>-sulfonylated aminosalicylic acids as dual MCL-1/BCL-xL inhibitors.
| S-EPMC9890589 | biostudies-literature
Unknown BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells.
| S-EPMC4727751 | biostudies-literature
Unknown Epigenetic Targeting of Mcl-1 Is Synthetically Lethal with Bcl-xL/Bcl-2 Inhibition in Model Systems of Glioblastoma.
| S-EPMC7464325 | biostudies-literature
Unknown Targeting BCL-XL for degradation synergizes with gemcitabine against cholangiocarcinoma.
| S-EPMC12930748 | biostudies-literature
Unknown Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems.
| S-EPMC6194027 | biostudies-literature